RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $100,525,000 | +2.3% | 2,093,839 | 0.0% | 0.62% | +18.6% |
| Q4 2019 | $98,264,000 | +77.1% | 2,093,839 | -10.7% | 0.52% | +38.5% |
| Q3 2019 | $55,471,000 | +2.4% | 2,345,496 | +30.2% | 0.38% | +2.4% |
| Q2 2019 | $54,177,000 | +193.8% | 1,801,695 | +118.9% | 0.37% | +211.9% |
| Q1 2019 | $18,438,000 | +23.1% | 823,113 | 0.0% | 0.12% | -4.1% |
| Q4 2018 | $14,981,000 | +365.4% | 823,113 | +362.5% | 0.12% | +485.7% |
| Q3 2018 | $3,219,000 | +81.8% | 177,952 | 0.0% | 0.02% | +61.5% |
| Q2 2018 | $1,771,000 | +87.4% | 177,952 | 0.0% | 0.01% | +62.5% |
| Q1 2018 | $945,000 | -37.5% | 177,952 | 0.0% | 0.01% | -38.5% |
| Q4 2017 | $1,513,000 | -41.8% | 177,952 | 0.0% | 0.01% | -38.1% |
| Q3 2017 | $2,598,000 | -22.1% | 177,952 | 0.0% | 0.02% | -27.6% |
| Q2 2017 | $3,335,000 | -12.0% | 177,952 | 0.0% | 0.03% | -6.5% |
| Q1 2017 | $3,789,000 | +40.2% | 177,952 | 0.0% | 0.03% | +19.2% |
| Q4 2016 | $2,703,000 | – | 177,952 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $145,183,000 | 12.02% |
| VHCP Management III, LLC | 670,350 | $15,854,000 | 9.79% |
| RA Capital Management | 4,858,260 | $114,898,000 | 6.85% |
| VHCP Management II, LLC | 677,164 | $16,015,000 | 6.10% |
| EMORY UNIVERSITY | 59,690 | $1,412,000 | 2.78% |
| SECTORAL ASSET MANAGEMENT INC | 451,247 | $10,672,000 | 1.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,728,019 | $40,868,000 | 1.67% |
| Opaleye Management Inc. | 141,800 | $3,354,000 | 1.21% |
| ACUTA CAPITAL PARTNERS, LLC | 55,000 | $1,301,000 | 0.94% |
| EAM Global Investors LLC | 69,035 | $1,633,000 | 0.80% |